Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in the peritoneal fluid in patients with peritonitis – is the key towards intraperitoneal adhesions and complications?

1. van Goor H, Bom VJ, van der Meer J, Sluiter WJ, Bleichrodt RP. Coagulation and fibrinolytic responses of human peritoneal fluid and plasma to bacterial peritonitis. Br J Surg 1996;83(8):1133-5.10.1002/bjs.18008308338869327Search in Google Scholar

2. Weijer S, Schoenmakers SHHF, Florquin S, Levi M, Vlasuk GP, Rote WE, et al. Inhibition of the Tissue Factor/Factor VIIa Pathway Does Not Influence the Inflammatory or Antibacterial Response to Abdominal Sepsis Induced by Escherichia coli in Mice. J Infect Dis 2004;189:2308-17.10.1086/42103115181580Search in Google Scholar

3. Pawlinski R, Mackman N. Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis. Crit Care Med 2004;32(5 Suppl):S293-7.10.1097/01.CCM.0000128445.95144.B8Search in Google Scholar

4. Hoefs J, Barnes T, Halle P. Intraperitoneal coagulation in chronic liver disease ascites. Dig Dis Sci 1981;26(6):518-22.10.1007/BF013081007238271Search in Google Scholar

5. Henderson JM, Stein SF, Kutner M, Wiles MB, Ansley JD, Rudman D. Analysis of Twenty-three plasma proteins in ascites. The depletion of fibrinogen and plasminogen. Ann Surg 1980;192(6):738-42.10.1097/00000658-198012000-0000813449737447527Search in Google Scholar

6. Agarwal S, Joyner KA Jr, Swaim MW. Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease. Am J Gastroenterol 2000;95(11):3218-24.10.1111/j.1572-0241.2000.03299.x11095345Search in Google Scholar

7. Koca YS, Tarhan ÖR, Kaya S, Gökçe Ceylan B. Effects of saline lavage temperature on peritoneal fibrinolysis and adhesion formation. Ulus Travma Acil Cerrahi Derg 2016;22(1):1-6.Search in Google Scholar

8. Aarons CB, Cohen PA, Gower A, Reed KL, Leeman SE, Stucchi AF, et al. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity. Ann Surg 2007;245(2):176-84.10.1097/01.sla.0000236627.07927.7c187699317245169Search in Google Scholar

9. Lakbakbi S, Debrumetz A, Rieu P, Nguyen P. Human Neutrophils Support Thrombin Generation in Peritonitis. Perit Dial Int 2015;35(5):599-602.10.3747/pdi.2014.00187459799926450485Search in Google Scholar

10. Szaba FM, Smiley ST. Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo. Blood 2002;99(3):1053-9.10.1182/blood.V99.3.1053Search in Google Scholar

11. van Veen SQ, Levi M, van Vliet AK, Florquin S, van Gulik TM, Boermeester MA. Peritoneal lavage with activated protein C alters compartmentalized coagulation and fibrinolysis and improves survival in polymicrobial peritonitis. Crit Care Med 2006;34(11):2799-805.10.1097/01.CCM.0000243795.04284.2A17006359Search in Google Scholar

12. Ray NF, Denton WG, Thamer M, Henderson SC, Perry S. Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg 1998;186(1):1-9.10.1016/S1072-7515(97)00127-0Search in Google Scholar

13. Dijkstra FR, Nieuwenhuijzen M, Reijnen MM, van Goor H. Recent clinical developments in pathophysiology, epidemiology, diagnosis and treatment of intra-abdominal adhesions. Scan J Gastroenterol 2000;232:52-9.Search in Google Scholar

14. Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992;12(1):14-27.10.1177/089686089201200105Search in Google Scholar

15. Parhami-Seren B, Butenas S, Krudysz-Amblo J, Mann KG. Immunologic quantitation of tissue factors. J Thromb Haemost 2006;4(8):1747-55.10.1111/j.1538-7836.2006.02000.x16879217Search in Google Scholar

16. Witkowski M, Landmesser U, Rauch U. Tissue factor as a link between inflammation and coagulation. Trends Cardiovasc Med 2016;26(4):297-303.10.1016/j.tcm.2015.12.00126877187Search in Google Scholar

17. Camerota AJ, Creasey AA, Patla V, Larkin VA, Fink MP. Delayed Treatment with Recombinant Human Tissue Factor Pathway Inhibitor Improves Survival in Rabbits with Gram-Negative Peritonitis. J Infect Dis 1998;177(3):668-76.10.1086/5142469498446Search in Google Scholar

18. Culp WTN, Holt DE. Septic peritonitis. Compend Contin Educ Vet 2010;32(10):E1-14.Search in Google Scholar

19. Haslinger B, Kleemann R, Toet KH, Kooistra T. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-α–activated human peritoneal mesothelial cells. Kidney Int 2003;63:2065-74.10.1046/j.1523-1755.2003.t01-2-00004.x12753293Search in Google Scholar

20. Schirm S, Liu X, Jennings LL, Jedrzejewski P, Dai Y, Hardy S. Fragmented Tissue Factor Pathway Inhibitor (TFPI) and TFPI C-Terminal Peptides Eliminate Serum-Resistant Escherichia coli from Blood Cultures. J Infect Dis 2009;199(12):1807-15.10.1086/59909719456231Search in Google Scholar

21. Mutsaers SE, Birnie K, Lansley S, Herrick SE, Lim CB, Prêle CM. Mesothelial cells in tissue repair and fibrosis. Front Pharmacol 2015;6:113. doi: 10.3389/fphar.2015.00113.446032726106328Open DOISearch in Google Scholar

22. Bajaj MS, Pendurthi U, Koenig K, Pueblitz S, Idell S. Tissue factor pathway inhibitor expression by human pleural mesothelial and mesothelioma cells. Eur Respir J 2000;15(6):1069-78.10.1034/j.1399-3003.2000.01515.x10885426Search in Google Scholar

23. Buyne OR, van Goor H, Bleichrodt RP, Verweij PE, Hendriks T. Both tissue-type plasminogen activator and urokinase prevent intraabdominal abscess formation after surgical treatment of peritonitis in the rat. Surgery 2008;144(1):66-73.10.1016/j.surg.2008.03.02518571586Search in Google Scholar

24. Isaza-Restrepo A, Martin-Saavedra JS, Velez-Leal JL, Vargas-Barato F, Riveros-Duenas R. The Peritoneum: Beyond the Tissue – A Review. Front Physiol 2018;9:738-745. doi: 10.3389/fphys.2018.00738.Open DOISearch in Google Scholar

25. Yung S, Li FK, Chan TM. Peritoneal mesothelial cell culture and biology. Perit Dial Int 2006;26(2):162-73.10.1177/089686080602600207Search in Google Scholar

26. Macarak EJ, Lotto CE, Koganti D, Jin X, Wermuth PJ, Olsson AK, et al. Trametinib prevents mesothelial-mesenchymal transition and ameliorates abdominal adhesion formation. J Surg Res 2018;227:198-210.10.1016/j.jss.2018.02.012Search in Google Scholar

27. Sitter T, Gödde M, Spannagl M, Fricke H, Kooistra T. Intraperitoneal coagulation and fibrinolysis during inflammation: In vivo and in vitro observations. Fibrinolysis 1996;10:99-104.10.1016/S0268-9499(96)80060-9Search in Google Scholar

28. Arung W, Meurisse M, Detr y O. Pathophysiolog y and prevention of postoperative peritoneal adhesions. World J Gastroenterol 2011;17(411):4545-53.10.3748/wjg.v17.i41.4545322509122147959Search in Google Scholar

29. Brinkmann T, Schmidt M, Prohaska W, Kleesiek K. Tissue Factor Pathway Inhibitor (TFPI): Biochemistry, Genetics, and Implications for Thrombophilia. J Lab Med 2001;25(7-8):269-76.10.1515/labm.2001.25.7-8.269Search in Google Scholar

30. Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol 2012;34(1):43-62.10.1007/s00281-011-0290-822037947Search in Google Scholar

31. Takasugi Y, Shiokawa Y, Kajikawa R, Oh J, Yamamoto Y, Sakata I, et al. Mesenteric venous thrombosis in a patient with congenital afibrinogenemia and diffuse peritonitis. Ann Hematol 2005;84(2):129-30.10.1007/s00277-004-0958-415503018Search in Google Scholar

32. van Veen SQ, Cheung CW, Meijers JC, van Gulik TM, Boermeester MA. Anticoagulant and anti-inflammatory effects after peritoneal lavage with antithrombin in experimental polymicrobial peritonitis. J Thromb Haemost 2006;4(11):2343-51.10.1111/j.1538-7836.2006.02167.x16911675Search in Google Scholar

33. Fareed J, Callas DD, Hoppensteadt D, Bermes EW Jr. Tissue factor antigen levels in various biological fluids. Blood Coagul Fibrinolysis 1995;6 Suppl 1:S32-6.10.1097/00001721-199506001-000067647218Search in Google Scholar

34. Hariharan D, Wilkes EA, Aithal GP, Travis SJ, Lobo DN. Spontaneous central venous thrombosis and shunt occlusion following peritoneovenous shunt placement for intractable ascites. Ann R Coll Surg Engl 2017;99(5):e145-e147.10.1308/rcsann.2017.0058544971228462645Search in Google Scholar

35. Thaler J, Hell L, Schwabl P, Wisgrill L, Ay C, Quehenberger P, et al. Intraperitoneal Activation of Blood Coagulation via Tissue Factor Exposing Extracellular Vesicles in Patients with Liver Disease and Ascites. Hamostaseologie 2019;39:S1-S92.10.1055/s-0039-1680114Search in Google Scholar

36. Goldfarb RD, Glock D, Johnson K, Creasey AA, Carr C, McCarthy RJ, et al. Randomized, blinded, placebo-controlled trial of tissue factor pathway inhibitor in porcine septic shock. Shock 1998;10(4):258-64.10.1097/00024382-199810000-000059788657Search in Google Scholar

37. Abraham E, Reinhart K, Opal S, Demeyer I, Doig Ch, Rodriguez AL, et al. Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis: a randomized controlled trial. JAMA 2003;290(2):238-47. doi: 10.1001/jama.290.2.238.12851279Open DOISearch in Google Scholar

38. Opal SM, Palardy JBA, Parejo NBA, Creasey AA. The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis. Crit Care Med 2001;29(1):13-7.10.1097/00003246-200101000-0000311176151Search in Google Scholar

39. Matyal R, Vin Y, Delude R, Lee C, Creasey A, Fink M. Extremely low doses of tissue factor pathway inhibitor decrease mortality in a rabbit model of septic shock. Intensive Care Med 2001;27:1274-80.10.1007/s00134010099211511939Search in Google Scholar